Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Shilpa Medicare Limited ( (IN:SHILPAMED) ) is now available.
Shilpa Medicare Limited has exited its investment in Koanna Healthcare Canada Inc., after the Canadian unit allotted 284,210,20 equity shares to individual buyer Steve N. Slilaty for a total consideration of CAD 2,000 under a share sale-purchase agreement dated 14 January 2026. As a result, Koanna Healthcare Canada Inc. has ceased to be a wholly owned subsidiary, though it was not classified as a material subsidiary and contributed only a negligible share to Shilpa Medicare’s income and net worth, meaning the transaction is not expected to have any impact on the company’s current financials or trigger related-party transaction concerns.
More about Shilpa Medicare Limited
Shilpa Medicare Limited is an India-based pharmaceutical company focused on developing and manufacturing specialty and generic drugs, with operations that include international subsidiaries such as Koanna Healthcare Canada Inc. The company serves global markets with a range of healthcare products and services, positioning itself within the broader pharmaceutical and healthcare industry.
Average Trading Volume: 25,779
Technical Sentiment Signal: Hold
Current Market Cap: 58.19B INR
Find detailed analytics on SHILPAMED stock on TipRanks’ Stock Analysis page.